1. Concomitant genomic alterations in KRAS mutant advanced lung adenocarcinoma. (February 2020) Authors: Gibert, Joan; Clavé, Sergi; Hardy-Werbin, Max; Taus, Álvaro; Rocha, Pedro; Longarón, Raquel; Piquer, Gabriel; Chaib, Imane; Carcereny, Enric; Morán, Teresa; Salido, Marta; Dalmases, Alba; Bellosillo, Beatriz; Arriola, Edurne Journal: Lung cancer Issue: Volume 140(2020) Page Start: 42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer. (3rd June 2019) Authors: Hardy-Werbin, Max; Rocha, Pedro; Arpi, Oriol; Taus, Álvaro; Nonell, Lara; Durán, Xavier; Villanueva, Xavier; Joseph-Pietras, Deborah; Nolan, Luke; Danson, Sarah; Griffiths, Richard; Lopez-Botet, Miguel; Rovira, Ana; Albanell, Joan; Ottensmeier, Christian; Arriola, Edurne Journal: Oncoimmunology Issue: Volume 8:Number 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Use of denosumab in a dialysis patient with bone metastases from breast cancer and hepatorenal polycystic disease: a case report. Issue 5 (June 2016) Authors: Quiroga García, Vanesa; Cirauqui Cirauqui, Beatriz; Tobey Robaina, Lyan; López Sisamon, David; Hardy-Werbin, Max; Blanca, Ana Belén; Margelí Vila, Mireia Journal: Anti-cancer drugs Issue: Volume 27:Issue 5(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗